The neurorestorative benefit of GW3965 treatment of stroke in mice.
The neurorestorative benefit of GW3965 treatment of stroke in mice.
复制标题
DOI:
10.1161/strokeaha.112.677682
复制
发表时间:
2013-01
期刊:
影响因子:
8.3
通讯作者:
Chen J
中科院分区:
文献类型:
--
作者:
Cui X;Chopp M;Zacharek A;Cui Y;Roberts C;Chen J
GW3965, a synthetic liver X receptor agonist, elevates high-density lipoprotein cholesterol (HDL-C) and has anti-atherosclerosis and anti-inflammation properties. We tested the hypothesis that GW3965 treatment of stroke increases vascular remodeling, promotes synapticprotein expression and axonal growth in the ischemic brain and improves functional outcome in mice. Mice were subjected to transient middle cerebral artery occlusion (MCAo) and treated without or with different doses of GW3965 (5, 10 or 20 mg/kg) starting 24 hours after MCAo daily for 14 days. Neurological functional tests, blood HDL-C measurement, and immunostaining were performed. Mouse brain endothelial cells, primary cultured artery explants and primary cortical neurons cultures were also employed in vitro. GW3965 treatment of stroke significantly increased blood HDL-C level, synaptic protein expression, axonal density, angiogenesis and arteriogenesis, and Angiopoietin1, Tie2 and occludin expression in the ischemic brain and improved functional outcome compared with MCAo control animals (P<0.05, n=10). In vitro, GW3965 and HDL also significantly increased capillary-like tube formation and artery explant cell migration as well as neurite outgrowth. Inhibition o f A n giopoietin1 attenuated GW3965-induced tube-formation, artery cell migration and neurite outgrowth (P<0.05, n=6/group). These data indicate, for the first time, that GW3965 promotessynaptic protein expression, axonal growth, and increases vascular remodeling which may contribute to improvement of functional outcome after stroke. Increasing Angiopoietin1/Tie2 signaling activity may play an important role in GW3965-induced brain plasticity and neurological recovery from stroke.